Flowtech Fluidpower’s (FLO) Buy Rating Reaffirmed at Shore Capital

Share on StockTwits

Flowtech Fluidpower (LON:FLO)‘s stock had its “buy” rating restated by analysts at Shore Capital in a research note issued on Friday, ThisIsMoney.Co.Uk reports.

Separately, FinnCap restated a “corporate” rating on shares of Flowtech Fluidpower in a research report on Friday.

Shares of LON:FLO opened at GBX 134.50 ($1.76) on Friday. The firm has a 50 day moving average price of GBX 136.92. The firm has a market cap of $82.22 million and a PE ratio of 16.20. The company has a quick ratio of 0.68, a current ratio of 1.40 and a debt-to-equity ratio of 25.31. Flowtech Fluidpower has a 12 month low of GBX 97 ($1.27) and a 12 month high of GBX 189.50 ($2.48).

About Flowtech Fluidpower

Flowtech Fluidpower plc, together with its subsidiaries, distributes hydraulic and pneumatic fluid power products in the United Kingdom, Ireland, Benelux, and internationally. The company operates through three segments: Flowtechnology, Power Motion Control, and Process. It offers hydraulic rubber and thermoplastic hose assembly kits, hydraulic cylinders and semi-rotary actuators, bespoke hydraulic power units and packs, purification and filtration systems, manipulated pipes and individual machined components, specialist valves and actuation equipment, safety pipework, transfer pumps, breather valves and instrumentals, and mobile systems, as well as various industrial, pneumatic, and hydraulic components.

Featured Article: Stock Portfolio Tracker

Receive News & Ratings for Flowtech Fluidpower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flowtech Fluidpower and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report